Wealth Creation with High Conviction Value Research based Stock Recommendations
Skin in the Game
We invest in most of the stocks we share reports on
Forbes and ET Recognized
Featured in Economic Times and Forbes India's 2015 edition of Wealth Wizards
29% + XIRR
Strong Outperformance over NIFTY and SENSEX over the last 9 years
Premium Members Served
Internal Rate of Return (XIRR)
Years of Investing Experience
Years of Katalyst Wealth
Founder, Katalyst Wealth
Coming from a family of Stock investors, Ekansh started investing in stocks at a very young age and founded Katalyst Wealth in 2011.
He got featured in Forbes India's 2015 edition of Wealth Wizards and Economic Times (ET) May 2017 edition of Dons of Dalal Street.
He is supported by an in-house Operations team.
Aarti Drugs - 524%
Can Fin Homes - 977%
Orient Refractories - 578%
Cera Sanitaryware - 1,075%
14-18 easy to understand reports on stocks that have the potential to grow multi-fold (multibagger) with the avg. holding period of 2-3 years.
Special Situation Opportunities (SSOs)
Reports on opportunities arising out of corporate actions like delisting, demerger, buyback, etc with avg. holding period of 3-5 months.
An excel sheet simulation of Portfolio performance on the basis of stock reports shared with members.
Access to all our active Investment Recommendations and Special situation opportunity reports, new or old
Latest updates with actionable insights on our recommendations to know where they stand and where they're headed next.
Not everyone grows up learning about markets, stock investing; but, if you want to learn more, you will get plenty of lessons from us
14- 18 Investment Reports
Past Reports (including closed)
14-18 Investment Reports
5-6 Special Situation Reports
Past Reports (including closed)
Presentation on Special Situation Opportunities in the Indian Stock Markets
It feels great to share with you an important piece of update on the work front. Recently, I got an opportunity to address the 2nd Year MBA students of MDI, Gurgaon, a premier Business school, consistently ranked in the top 10. The address was a part of the Behavioral Finance & Business Valuation (BFBV) course as covered by Prof. Sanjay Bakshi and the topic was Special Situation Opportunities in the Indian Stock Markets. Despite the initial nervousness, the presentation went
How to Identify Stocks with Low Downside Risk and Potential for Large Gains?...Backed with Examples
Dear Sir, Hope you are doing well. Today, I would like to share with you our thought process on how to identify stocks with low downside risk and potential for high pay offs. I think you will agree with the following two facts: All the businesses are cyclical to varying extents and go through lean periods, and Best returns are generated when a company goes through both Earnings and PE expansion Thus, if you combine the two, we get the
[Recommendation] - Delisting Opportunity - Low Downside and Expecting Promoters to buy out at higher price
Dear Sir, It’s always great to participate in Special situation opportunities (SSOs) as there can be decent gains in relatively shorter duration of 3-4 months. We have also benefited from this strategy with several Special Situation opportunities like Ineos Styrosolution delisting, Suven life-Suven Pharma demerger, Linde India delisting, Hexaware delisting, Xchanging Solutions delisting, etc appreciating by 20-140% in a period of 2-11 months. So, just 2 days back we released our New Special Situation stock report and we think you may find the logic behind the same interesting as there’s a
[New Stock Recommendation] - 0 to 1000 crore + sales in 18 years...Stock at 12-13 PE
Hope you all are doing good and taking proper precautions. We recently shared our new stock recommendation with our Premium Members and would like to share with you details about the same. As discussed in our Risk categorization update, we have been focusing on leading well-managed companies which will probably emerge stronger from this pandemic and capture higher market share in the years to come. Have also benefited from this strategy with stocks like Aarti Drugs, Suven Pharma, Chaman Lal,
Model Portfolio: 23% + return against -3.4% by NIFTY
Dear Sir, Hope you are doing well. We have been maintaining Alpha and Alpha + Model Sheets since 15th Aug’18 and would like to share with you our Performance card (as on 25th Sep’20). We believe the performance has been decent with absolute returns of over 23% (20-21.5% without interest) since 15th Aug’18 against -3% to -24.5% for major benchmark indices. The last 2-2.5 years have been really tough for the investors in general and therefore it feels good to have still delivered around 11% CAGR. The Model Sheet service
Acrysil Ltd - Interesting notes from Annual Report 2020
Dear Readers, We read several annual reports in a year and make notes for our reference. We believe Annual Reports are one of the best documents to increase your understanding of the company. However, do keep in mind, such notes are mostly cut, copy and paste from the annual reports of the companies and are in no way a research report or a recommendation on the stock. Here are some interesting details from the Annual Report 2020 of Acrysil Ltd: General
Katalyst Wealth's stock research has been consistently accurate over the years. Their approach is conservative but still regularly find out quality stock-picks at mouth-watering valuations. They put the client's interests first.
Subscriber, Abu Dhabi and Author of "A Safari in the Equity World"
Your service is exceptionally good, stock picks are excellent and well-researched and most importantly you guys are transparent and frank when some stock misfires. Looking forward to many years of Symbiotic relationship.
Ekansh does wonderful research. His ideas have good growth potential with balanced risk. I have been a subscriber for last 3 years and have learnt a lot from his write-ups.
Subscriber, Lucknow and Co-Founder 'Screener.in'
I sincerely thank you for your genuine research on stocks such as Suven Lifesciences, Manappuram Finance and many more. They have helped me not only grow my money but also my confidence to invest in stock market.
Subscriber, New Delhi
I have been your client for more than 7 years now. Your services and research are simply excellent and my capital has appreciated greatly. Thanks for the same.
I trust your sincerity and dedication. The value you bring through your research is much more than what you charge. It's really good I found you. I feel safe even in negative market environment.
Subscriber, Newcastle, Australia
Monday - Friday
10am - 5pm
7, Panch Ratan, 7/128
Swaroop Nagar, Kanpur - 208002
WHO WE ARE
www.katalystwealth.com (herein referred to as 'Katalyst Wealth') is the domain owned by Mittal Consulting (Ekansh Mittal is the Sole Proprieotor). We offer Independent Equity research services to investors on subscription basis. SEBI (Research Analyst) Registration No. INH100001690
Copyright ©2020 Mittal Consulting. All rights reserved.